Share

Janssen Research & Development

Personal Stories

4 Things COVID-19 Taught an ER Doctor About the Power of Resilience and Hope

4 Things COVID-19 Taught an ER Doctor About the Power of Resilience and Hope

At the height of the outbreak in New York City, Dr. Ed Kuffner took a leave of absence from his job to volunteer at a Brooklyn hospital hard hit by the pandemic. He shares what the experience taught him about his own strengths—and ideas for coping during this unprecedented time.

Dr. Ed Kuffner wearing PPE

Innovation

"I'm Racing to Screen Thousands of Molecules": These Scientists Are Canvassing a Vast Library in Search of a Potential COVID-19 Treatment

"I'm Racing to Screen Thousands of Molecules": These Scientists Are Canvassing a Vast Library in Search of a Potential COVID-19 Treatment

Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.

Two scientists in a lab

Innovation

Alzheimer’s Disease: Why One Company Refuses to Give Up the Search for a Cure

Alzheimer’s Disease: Why One Company Refuses to Give Up the Search for a Cure

It's the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.

Innovation

Cracking the Genetic Code: Why Gene Sequencing May Hold the Key to Intercepting Diseases Before They Start

Cracking the Genetic Code: Why Gene Sequencing May Hold the Key to Intercepting Diseases Before They Start

Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.

Scientist observing genes

Innovation

Have IBD? Read About the Next Frontier in Disease Research That Taps Into the Microbiome

Have IBD? Read About the Next Frontier in Disease Research That Taps Into the Microbiome

There are trillions of microorganisms living in your gut—and they might just be the key to helping treat diseases like Crohn's and ulcerative colitis. Meet a researcher who spends her days exploring this microscopic world.

Esi Lamousé-Smith in the lab with colleagues reviewing microbial data

Innovation

Clinical Trials 2.0: 5 Ways Johnson & Johnson Is Helping Revamp—and Revolutionize—How They're Conducted

Clinical Trials 2.0: 5 Ways Johnson & Johnson Is Helping Revamp—and Revolutionize—How They're Conducted

From working to broaden the pool of patients trials have traditionally studied to finding ways for people to participate from the comforts of home, we look at how the company is reinventing clinical trials in truly forward-thinking ways.

Innovation

4 Questions for a Scientist Determined to Find a Functional Cure for Hepatitis B

4 Questions for a Scientist Determined to Find a Functional Cure for Hepatitis B

Despite being one of the oldest viruses known to infect man, there's been slow progress toward a cure for the disease. But a promising clinical trial, led by Janssen researcher Heather Davis, Ph.D., is sparking hope.

Dr. Heather Davis with her colleagues in a research laboratory

Latest News

New Study Shows Researchers May Be One Step Closer to Intercepting Lung Cancer Earlier

New Study Shows Researchers May Be One Step Closer to Intercepting Lung Cancer Earlier

A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.

Doctors looking at a lung scan on a tablet

Latest News

5 Things to Know About the 2018 Janssen U.S. Transparency Report

5 Things to Know About the 2018 Janssen U.S. Transparency Report

The company just released its third annual report and leaders from across Janssen share some top takeaways, including a new initiative to include the list price and potential out-of-pocket costs for its most frequently prescribed medicine.

Two researchers looking at a computer screen in a lab

Innovation

New Year, New Vision: Meet a Woman Determined to Find a Cure for Type 2 Diabetes

New Year, New Vision: Meet a Woman Determined to Find a Cure for Type 2 Diabetes

Hundreds of millions of people worldwide have type 2 diabetes. And Chiara Magnone has her sights set on changing what it means to live with the condition, as well as how common complications like chronic kidney disease are treated.

Latest News

Johnson & Johnson's New Chief Financial Officer Answers 7 Popular Investor Questions

Johnson & Johnson's New Chief Financial Officer Answers 7 Popular Investor Questions

Joe Wolk, who has enjoyed a 20-year tenure at Johnson & Johnson, shares his vision for the company's fiscal future.

Health & Wellness

5 Things We Now Know About Prostate Cancer

5 Things We Now Know About Prostate Cancer

For Men's Health Month, school yourself on the latest screenings and treatments for this most common male cancer.

Innovation

In Search of the Next Great Female Thinkers: Why Johnson & Johnson Is on a STEM2D Mission

In Search of the Next Great Female Thinkers: Why Johnson & Johnson Is on a STEM2D Mission

The company just awarded six promising female researchers $150,000 each through its new Scholars Award program—and that's not the only way it's helping women working in the sciences.

Innovation

Ebola: The Fight Continues Four Years After the Worst Outbreak in History

Ebola: The Fight Continues Four Years After the Worst Outbreak in History

Macaya Douoguih volunteered to lead an accelerated clinical program for a new investigational Ebola vaccine at the height of the 2014 epidemic in West Africa. She reflects on her experiences—and why her work must continue today.

Latest News

5 Things to Know About the 2017 Janssen U.S. Transparency Report

5 Things to Know About the 2017 Janssen U.S. Transparency Report

The company just released its second-annual report and we're spotlighting the top takeaways for patients, consumers and healthcare professionals, including a look at how Janssen approaches drug pricing.

Load More